Each point was worked out with the data available that day. Scale 0-10: 5 is the index average and 10 is the cap (+3 standard deviations), not perfection. The vertical axis zooms to fit this company, so two charts are not comparable by eye.
Market and Valuation
Price & Market
Prev Close Price:$436.87
Open:$436.65
Day's Low:$434.05
Day's High:$443.58
Bid / Ask:-
Market Cap:155.71B
Enterprise Value:147.53B
52-Week Range
52-Week Low:$328.57
52-Week High:$603.88
Current position in 52-week range
52w Low-52w High
50-Day Avg:$402.70
200-Day Avg:$432.54
Volume
Volume Today:1,708,934
Avg Volume (3m):2,437,117
Avg Volume (10d):2,980,410
52-Week Change:-18.92%
vs S&P 500, 52 weeks:-
Beta:1.44
Valuation Multiples
P/E (trailing):53.36
Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 21, 2026. The P/E is the price divided by that EPS.
P/E (forward):35.35
PEG Ratio:2.02
Price / Book:9.56
Price / Sales (TTM):13.45
EV / Revenue:12.74
EV / EBITDA:33.00
Dividends
Current yield:-
Annual Dividend Rate:-
Dividend Trailing:$0.00
Yield Trailing:0.00%
5-Year Avg Yield:-
Payout Ratio:0.00%
Last Ex-Dividend Date:-
Valuation Context
P/E vs sector (indicative)
Most Recent Quarter:-
Fiscal Year (Next):-
Loading historical OHLCV database...
Date
Open
High
Low
Close
Volume
Financial Statements TTM (Trailing 12 Months)
Income Statement
Total Revenue (TTM):11.58B
Gross Profit:7.72B
EBITDA:4.47B
Net Income (TTM):2.96B
Rev Growth (YoY):+21.70%
Earnings Growth (YoY):-23.60%
Quarterly earnings growth (YoY):-25.80%
Margins
Gross Margin:-
EBITDA Margin:-
Operating Margin:-
Net Margin:-
Per Share
EPS Trailing (TTM):$8.26
Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 21, 2026. The P/E is the price divided by that EPS.
EPS Forward (Est.):$12.47
Revenue Per Share:$32.78
Cash Per Share:-
Book Value:$46.12
Last Dividend:-
Ex-Dividend Date:-
Last Split:-
Balance Sheet & Liquidity
Total cash:4.04B
Total Debt:0
Net Debt (Debt - Cash):−4.04B (net cash)
Debt / Equity:-
Current Ratio:3.33
Quick Ratio:2.32
Cash Flows
Operating Cash Flow:4.09B
Free Cash Flow (FCF):3.43B
FCF Yield (FCF / Market Cap):-
Enterprise Value:147.53B
EV / Revenue:12.74
EV / EBITDA:33.00
Profitability
ROE (Return on Equity):17.93%
ROA (Return on Assets):11.85%
P/E (trailing):53.36
P/E (forward):35.35
Price / Book:9.56
PEG Ratio:2.02
52-Week Change:-18.92%
S&P 500 change, 52 weeks:+11.37%
Historical Evolution (Last 4 Years)
Income Statement
Balance Sheet
Cash Flow
EPS and Earnings Per Share
Key EPS Metrics
EPS Trailing (TTM):$8.26
Diluted EPS for the last 12 months: the four quarters ended Sep 30, 2026, from the accounts filed with the SEC on Oct 21, 2026. The P/E is the price divided by that EPS.
EPS Forward (Est.):$12.47
P/E (forward):35.35
PEG Ratio:2.02
Growth and Margins
Earnings Growth YoY:-
Quarterly Earnings Growth YoY:-
Rev Growth YoY:-
Net Margin:-
Gross Margin:-
EBITDA Margin:-
Per Share
Revenue Per Share:$32.78
Cash Per Share:-
Book Value:$46.12
Cash Flows (TTM)
Free Cash Flow:3.43B
Operating Cash Flow:4.09B
EBITDA:4.47B
Total Revenue (TTM):11.58B
Net Income (TTM):2.96B
Fiscal Year (Last):-
EPS Surprise History - Last 4 Quarters
Actual vs. Analyst Estimates · Green = beat expectations · Red = missed
Quarter
Period
Actual EPS
Estimated EPS
Difference
Surprise %
Currency
Ownership Structure
Ownership Distribution
% Insiders:-
% Institutional:-
% Inst. (of Float):-
No. of Institutions:-
Visual distribution
InsidersInstitutionalFree Float
Shares & Short Interest
Shares Outstanding:353,278,038
Float (free shares):344,598,520
Short interest (shares):7,325,463
Short % of float:-
Short Ratio (days to cover):3.49
Short interest, prior month:-
Short Interest Date:-
Governance Score (1=Best, 10=Worst)
Overall risk:-
Audit Risk:-
Board risk:-
Compensation Risk:-
Shareholder rights risk:-
Top Institutional Holders
Position Change: ▲ Increased · ▼ Reduced · = Unchanged
Organization
Report Date
% Shares
No. Shares
Value (USD)
Change %
Top Mutual Funds
Position Change: ▲ Increased ▼ Decreased = Unchanged
Fund
Report Date
% Shares
No. Shares
Value (USD)
Change %
Recent Insider Trades
Executive / Insider
Title
Date
Action
Shares
Options Chain
CALLS
Strike
Last
Bid
Ask
Vol.
O.I.
IV
PUTS
Strike
Last
Bid
Ask
Vol.
O.I.
IV
Sentiment Metrics
Put/Call Ratio (Volume):-
Put/Call Ratio (O.I.):-
Max Pain (estimated):-
Total O.I. Calls:-
Total O.I. Puts:-
Expected move
Average IV (Calls ATM):-
Average IV (Puts ATM):-
Days to Expiration:-
Expected move (±):-
Intuitive Surgical, Inc. (ISRG) SEC filings: 10-K, 10-Q and 8-K
Direct links to financial reports filed with the SEC.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
VP, Principal Accounting Officer & Corporate Controller
-
-
Mr. Milind Wagle
Chief Information Officer
-
-
You have seen the engine room
A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.
No card. No spam.
Intuitive Surgical, Inc. (ISRG): Quantitative Analysis
Intuitive Surgical, Inc. (ISRG) — Healthcare — Medical Instruments & Supplies. ISRG is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.
So far in 2026, ISRG has returned −22.2% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.
ISRG ranks 367 of 461 on today's multifactor score, and 47 of the 55 Healthcare companies that score. Its strongest factor is quality (Z 0.49, ranked 75 of 468); its weakest is momentum (Z -1.05, ranked 441 of 494). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.
Factor scores
The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.
Frequently asked questions about Intuitive Surgical (ISRG)
When does Intuitive Surgical report earnings?
Intuitive Surgical has no announced date in the Nasdaq public calendar checked (Nov 3, 2026 to Dec 7, 2026). Of its last 12 earnings announcements: 11 after the close (and 1 with no time on the filing) (SEC filings through Oct 20, 2026). ISRG earnings dates and times, quarter by quarter →
What is Intuitive Surgical's P/E ratio?
Intuitive Surgical's P/E (price over earnings per share for the last twelve months) is 53.4 at the Nov 3, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Sep 30, 2026. The median of the 54 Healthcare companies with a P/E is 30.5, and the S&P 500's, 23.5: Intuitive Surgical is above its sector median. Healthcare stocks, company by company →
Where does Intuitive Surgical rank on Quant500?
In the Nov 3, 2026 multi-factor ranking, Intuitive Surgical ranks 367 of 461, and 47 of the 55 Healthcare companies that score. The ranking orders S&P 500 companies by the average of four factors (momentum, value, quality and growth) and is recalculated every trading day. It is a model output, not investment advice. The full ranking →How it is calculated →
Have Intuitive Surgical insiders bought or sold shares?
SEC Form 4 shows no open-market purchase of Intuitive Surgical shares from August 2025 through Nov 3, 2026. The latest sale was on Oct 30, 2026, by an officer, for $2.4M. In total, from August 2025 through Nov 3, 2026: 0 purchases and 81 sales by directors, officers and large shareholders. All ISRG insider trades →
What sector is Intuitive Surgical in, and which index?
Intuitive Surgical is classified in the Healthcare sector (industry: Medical Instruments & Supplies), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 59 S&P 500 companies in that sector. Healthcare stocks →
What is behind these numbers
The concepts on this page, explained from scratch in the Academy. Free, no account.
Quality and low volatilityWhere the quality score comes from, and why it is the factor with the most competing definitions, all of them called the same thing.
We save the portfolios you design, your own portfolio and your Academy progress, synced across devices.
Free, no card. Two automatic emails and no more: the one that confirms your address and the welcome one. After that, nothing you do not switch on yourself in your profile — such as the alert for insider buys, the same day they are reported to the SEC.